|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Total current assets | |||||||||||||
| Cash held in Trust Account | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Total current liabilities | |||||||||||||
| Promissory note – related party | |||||||||||||
| Convertible promissory note | |||||||||||||
| Loan and transfer agreement, net of debt discount | |||||||||||||
| Due to related party | |||||||||||||
| Deferred legal fees | |||||||||||||
| Deferred underwriting commissions | |||||||||||||
| Derivative warrant liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 15,519,813 and 17,264,702 shares issued and outstanding at approximately $10.96 and $10.61 at June 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Shareholders' Deficit | |||||||||||||
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at June 30, 2024 and December 31, 2023 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total shareholders' deficit | |||||||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | |||||||||||||
Loading...
